What Ecnoglutide is
Ecnoglutide is an investigational GLP-1 receptor agonist in the obesity and metabolic-disease pipeline.
Ecnoglutide is grouped under Fat Loss + GLP-1s / Approved / Clinical on PeptideFactCheck because it shows up in the broader race to build new GLP-1 or incretin medicines beyond the current leaders.
The useful starting point is to separate the molecule itself from the internet story around it. It shows up in the broader race to build new GLP-1 or incretin medicines beyond the current leaders.
Why people keep looking it up
It shows up in the broader race to build new GLP-1 or incretin medicines beyond the current leaders.
Ecnoglutide is an investigational GLP-1 receptor agonist in the obesity and metabolic-disease pipeline.
Ecnoglutide tends to stay in the conversation because it touches a familiar public theme: glp-1 receptor, appetite signaling, and weight loss. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
Early human metabolic evidence without approval status.
Human data exists, but this remains clinical-stage rather than a settled approved therapy.
Mechanistic support follows established GLP-1 pharmacology.
Why this page carries the current tier: Early human metabolic evidence without approval status.
The current seed trail for Ecnoglutide is pulling from 1 literature source, 1 trials source, 1 databases source, and 1 safety source.
Safety, limits, and regulatory context
GLP-1 development candidates should be discussed with the same caution as other investigational drugs.
Ecnoglutide remains investigational in the current record.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Ecnoglutide. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Molecular and identifier data
The current PubChem match for Ecnoglutide is CID 162625103. That gives the page a source-backed chemistry record rather than a placeholder identifier block.
- PubChem CID
- 162625103
- Formula
- C194H304N48O61
- Molecular weight
- 4285
- InChIKey
- DJMLKAVQDZZBNC-NYHUXPQOSA-N
Matched synonyms include Ecnoglutide, 2459531-73-6, Ecnoglutide [INN], UNII-KM6YM7L8LH, KM6YM7L8LH, GTPL13970, GLXC-26838, XW003.
Open PubChem recordClinical trial snapshot
The current ClinicalTrials.gov intervention query for Ecnoglutide returns 11 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
Literature snapshot
The current PubMed query for Ecnoglutide returns 9 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.